PAX2, PAX8, and PR are correlated with ovarian seromucinous borderline tumor with endometriosis.
Yun BS, Won S, Kim JH, Lee N, Kim M, Kim MK, Kim ML, Jung YW, Kim JY, Seong SJ, Shin E.
J Ovarian Res. 2022 Apr 6;15(1):41. doi: 10.1186/s13048-022-00975-5.
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 2.
Goodman NF, Cobin RH, Futterweit W, Glueck JS, Legro RS, Carmina E; American Association of Clinical Endocrinologists (AACE); American College of Endocrinology (ACE); Androgen Excess and PCOS Society.
Endocr Pract. 2015 Dec;21(12):1415-26. doi: 10.4158/EP15748.DSCPT2.
Ovarian cancer during pregnancy.
Gezginç K, Karataylı R, Yazıcı F, Acar A, Celik C, Capar M.
Int J Gynaecol Obstet. 2011 Nov;115(2):140-3. doi: 10.1016/j.ijgo.2011.05.025. Epub 2011 Aug 26.
Primary borderline parovarian tumor in pregnancy.
Kim JH, Cho DH.
Obstet Gynecol Sci. 2015 Nov;58(6):533-6. doi: 10.5468/ogs.2015.58.6.533. Epub 2015 Nov 16.
Fertility sparing treatments in young patients with gynecological cancers: Iranian experience and literature review.
Karimi Zarchi M, Mousavi A, Gilani MM, Barooti E, Amini Rad O, Ghaemmaghami F, Teimoori S, Behtas N.
Asian Pac J Cancer Prev. 2011;12(8):1887-92.
Gynecological cancer during pregnancy-From a gyne-oncological perspective.
Bohlin KS, Brännström M, Dahm-Kähler P.
Acta Obstet Gynecol Scand. 2024 Apr;103(4):761-766. doi: 10.1111/aogs.14763. Epub 2024 Jan 6.
Borderline ovarian tumors.
Chambers JT, Merino MJ, Kohorn EI, Schwartz PE.
Am J Obstet Gynecol. 1988 Nov;159(5):1088-94. doi: 10.1016/0002-9378(88)90419-x.
Therapy for cutaneous melanoma: an update.
Ho VC, Sober AJ.
J Am Acad Dermatol. 1990 Feb;22(2 Pt 1):159-76. doi: 10.1016/0190-9622(90)70019-e.
Phyllodes tumours of the breast: retrospective analysis of a University Hospital's experience.
Toh YF, Cheah PL, Looi LM, Teoh KH, Tan PH.
Malays J Pathol. 2016 Apr;38(1):19-24.
[Prognosis and fertility outcomes of patients with borderline ovarian tumors after fertility-sparing surgery].
Zhang Y, Wang QN, Huang Z, Chu R, Dong TT, Zhang YZ, Yang XS, Jiang J, Cui BX, Song K, Kong B.
Zhonghua Yi Xue Za Zhi. 2022 Jul 12;102(26):1999-2004. doi: 10.3760/cma.j.cn112137-20211215-02796.
